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In both developed and developing countries osteoporosis is a growing health problem that is 
well recognized. This contributes greatly to the high costs of  health care and mortality. 
Osteoporosis is a disease that is associated with fractures. This is a cause for worry solely 
because the results are lowered quality of life, people are no longer mobile, occurrences of 
disability and deaths. 
This bachelor thesis focuses on providing patient education on prevention of osteoporosis in 
menopause and also to produce information in terveys netti.  
The method used in this bachelor thesis is literature review. This thesis explains what 
osteoporosis is, causes, symptoms and complications. It further gives the step by step health 
education to the public on prevention, diagnoses and interventions. 
However, osteoporosis should no longer be considered an old womans disease but rather 
young women should also be included. Regular physical activity, healthy eating and not 
smoking can prevent and alleviate problems associated with age-related loss of muscle strength 
and bone density. 
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1 INTRODUCTION 
In both developed and developing countries osteoporosis is a growing health 
problem that is well recognized. This contributes greatly to the high costs of  
health care and mortality. This is therefore reason enough to conduct 
epidemiologic surveys inorder to know the prevalence of osteoporosis and 
related risk factors within communities. By doing this, long lasting solutions for 
prevention and control are achieved. (Solomon et al 2005,194.) 
One way to recognize that an individual has osteoporosis is the occurrence of  
fractures because this two are related. This is a cause for worry solely because 
the results are lowered quality of life, people are no longer mobile, occurrences 
of disability and deaths. According to world health organization, osteoporosis is 
associated with fractures hence making it  a risk factor and this fractures accur 
at various sites namely: wrist, spine and hip.  The risk factors for fractures are 
classified as  preventable and unpreventable. Most abvious unpreventable 
factor is being female. (Hertzman and Johnell 2006,7.)  
According to Ahlborg et al. 2010, an increase in the number of fractures globally 
has come about due  to increasing proportion of elderly women in the society. In 
Finland,  incidence of hip fractures in women aged 50 years or above increased 
by 60% between 1970 and 1997 , and in comparison to other regions reports 
and figures, the pattern is stabilizing.  (Kannus et al 1999,802.) 
According to osteoporosis foundation fact sheet, 1 in 3 women who are over 50 
years will suffer a fracture due to osteoporosis and  this increases to 1 in 2 who 
are  over 60 years of age. Approximately 1.6 million hip fractures occur each 
year worldwide, the incidence is set to increase to 6.3 million by 2050. The 
highest risk of hip fractures are seen in Norway, Sweden, Iceland, Denmark and 
the USA. ( IOF 2002.) 
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Currently, there is an increasing incidence of hip fractures in the developed 
cities in Asia. This is due to socio-economic development in many Asian 
countries and rapid ageing of the Asian population.  1 out of 4 hip fractures 
occur in Asia and Latin America. This number of hip fractures will increase to 1 
in 2 by 2050. ( IOF 2002.) 
Of the 1.5 million fractures that occur in the United States each year, 20% occur 
at the hip, 50% in the spine, and 30% at the wrist and other sites. The annual 
worldwide incidence of fracture was estimated to be 1.29 million in l990, and is 
projected to grow to 2.6 million by 2025 and to 4.5 million by 2050. (WHO, 
2003) 
The highest fracture rates are reported from northern Europe, the northern part 
of the United States, and among South east Asian populations, with the lowest 
rate from African countries. The risk of hip fracture among Norwegians is four 
times that of southern Europeans and double that of Americans. It is of note that 
the differences in incidence of hip fractures between countries are greater than 
the differences between genders. (Chang et al 2003,4.) 
Ageing men are also prone to being diagnosed with osteoporosis but  to a 
lesser degree than women. Women suffer more because they live longer than 
men  due to bone loss that occurs during  and  after menopause. This is why 
there are three to four times reported cases of hip fractures in women than men. 
(Melton  et al. 1993,118.) 
Another notable reason why osteoporosis is more common in women  is due to 
the fact that  bone loss in men starts later and the progression is slow. Men also 
have an advantage of not having a period of rapid hormonal change and 
accompanying rapid bone loss. In women the  peak bone mass is lower due to  
the hormonal changes that occur at menopause and the effect of pregnancy. 
Women need to be caucious about their diet and ensure that it is well balance 
because failure to observe this, and given the hormonal changes, calcium 
composition in their bodies can be altered. Taking calcium supplementation is 
also advised. (Melton  et al. 1993,119.) 
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While these diseases and consequent fractures, spontaneous or caused by 
falls, place an enormous burden on the health care system and society, often 
they do not get the attention they deserve because they are incorrectly seen as 
an inevitable part of ageing or less serious than such conditions as heart 
disease or cancer. (Melton  et al. 1993,119.) 
Unpreventable risk factors are:  Age, inherited genes , ethnicity,  being tall  
female gender  and menopause happening earlier than usual. Preventable risk 
factors are: Smoking, excessive alcohol consumption, impaired vision, lack of 
exercise or not doing enough, low weight, use of corticosteroids, secondary 
osteoporosis, falling often , inadequate sunlight and low bone density. This 
bachelor thesis will focus on prevention of osteoporosis in menopause. 
Menopause accurs over a period of several years and more so continuously 
meaning ones it starts, it goes on and on. It marks the end of a womans 
monthly period  but symptoms begin earlier with exception of some women 
whose symptoms shows months or years after menopause has occurred. The 
peak amount of bone attained before menopause and the rate of the bone loss 
thereafter determine how an ageing woman’s  skeleton will be. (Hertzman and 
Johnell 2006,7.) 
According to Ahlborg et al. , by   the year 2050, the occurrence of hip fractures 
will rise globally in the female gender by 240% and male gender by 310 %. The 
estimated number of hip fractures worldwide will rise from 1.66 million  from 
1990 to 6.26 million in 2050. This disease progresses fast and hence the 
importance of patient education. The increasing rate of hip fractures could be 
partly attributed to the number of increasing propotion of elderly women in the 
society. (Sambrook and Cooper 2006,12.) 
2 OSTEOPOROSIS 
Osteoporosis, like many diseases, has a general definition as well as more 
specific definitions by specialists in the field.  
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According to the national osteoporosis society (NOS), osteoporosis is a chronic 
disease and it’s clinical consequences occur late and are detected late. (WHO 
1994.) 
It happens silently and suddenly and it’s signs and symptoms are seen after a 
fracture has already occurred.  This skeletal disorder affects of osseous tissue 
that form bones by decreasing density and increasing brittleness and this  
results  in compromised bone strength, which places an individual at risk of 
fracture. It can be defined further as systematic and also happens continuously 
over a given span of time. It is a skeletal disease that results in  low bone mass 
and deterioration of the small structures in the bones. This make the bones 
fragile and more prone to fractures. (WHO 1994.) 
Osteoporosis classification system is based on measurements of the bone 
mineral density  of women. A woman’s actual BMD is assessed and then 
compared to the average peak BMD of a healthy young adult same sex and 
ethnicity. The woman’s deviation from this average is then calculated in 
standardized units. Women are considered to have a normal BMD if their score 
falls within 1 SD of the mean. Those whose BMD score falls within 1 to 2 SDs 
below the mean are classified as having osteopenia, a condition in which the 
bone loss is not severe enough to warrant classification as osteoporosis. The 
classification of osteoporosis is given to those whose BMD score is greater than 
or equal to 2.5 SDs below the mean. Women who have a history of fragility 
fractures and a BMD score greater than or equal to 2.5 SDs below the mean 
are classified as having severe or established osteoporosis. (Gueldner & Sarah 
2007,9.) 
After the third decade of life (30 years), bone naturally begins to decline at the 
rate of 0.3% of bone per year. By 2 years postmenopause,  bone mass declines 
at the rate of 3 % per year and 7 years after menopause bone loss slows to 
approximately 1 % of bone per year. (Golden ,H.2000, 542.) 
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It is a disease with subtle or gradual onset. It progresses gradually  and without 
warning signs. It is not possible to point out a time when the symptoms began. 
Many people with osteoporosis do not even know it and the doctors or their 
health care providers have not also detected it until a fracture occurs or they 
have their bone mass is tested and a correct diagnosis is made. (Searle 
2001,4.) 
In this  bone disorder  the bones become porous and this  results from loss of 
calcium in bones and as a result the bones become  brittle and susceptible to 
breaking. It is a silent disease hence impossible to diagnose  until a person 
suffers  a fracture or a broken bone. Osteoporosis may be classified as either 
primary and secondary. Primary osteoporosis is age related in both genders 
and there is occurrence of bone loss. In primary osteoporosis, the natural 
liifelong process where mature bone tissue is removed from the skeleton is 
normal, but the  process where by bone is broken down,  minerals released and  
transfer of calcium from bone fluid to the blood is incomplete. (Skinner 2003,3.) 
This type one can further be divided into two types. Type 1 also known as 
postmenopausal osteoporosis occurs in 5% to 20% of women, affecting those 
within 15 to 20 years of menopause, with a peak incidence in the 60s and early 
70s. The main causative factor is estrogen deficiency and as a result the 
skeleton  becomes more sensitive to parathyroid hormone (PTH), resulting in 
increased calcium resorption from bone. The ultimate result is a  decreases in 
PTH secretion, vitamin D production, and calcium absorption and hence the 
occurrence of fracture and bone loss. (Daniel 1996,558.) 
After the onset of menopause, women can lose an average of 2.5% of their 
bone per year for the first 5 years. Because of the drop in estrogen production, 
women lose nearly 50% of their trabecular bone and 35% of their cortical bone 
throughout their lifetime. (Iqbal 2000, 3.) 
Type 2 is age related and is also known as senile osteoporosis and happens to 
individuals who are 70 years of age in both genders. Decreased bone formation 
along and decreased ability of the kidney to produce Calcitriol.  
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Calcitriol is a form of vitamin D that is used to treat and prevent low levels of 
calcium in the blood of patients whose kidneys or parathyroid glands are not 
working normally. Calcium absorption lowers as when there is vitamin D 
deficiency which increases the PTH level and consequently  bone resorption. In  
type 2 osteoporosis, the risk of hip fractures is high as well. (Iqbal 2000, 3.) 
Secondary osteoporosis occurs equally in men and women  at any age. In men, 
most cases are due to disease or to drug therapy, but in most  of affected 
individuals the cause is not known. In various series of osteoporotic patients, 
secondary osteoporosis accounts for about 40% of the total number of 
osteoporotic fractures seen by a physician.This type of osteoporosis is 
associated with a variety of conditions  including hormonal imbalances, cancer, 
gastrointestinal disorders, drug use. (Iqbal 2000,3.)  
 
2.1 Normal bone 
Bone is living tissue that increases in length, weight (mass), mineral content 
(density), and strength during childhood and adolescence. Pregnancy marks the 
start of a new  life and in the second month of pregnancy, bone formation 
begins. In the 5th week of pregnancy  limb buds develop. This is followed by 
development of connective tissues. From the 7th week to the 6th month of 
uterine life there is cartilage and bone development. (Downey & Siegal, 2006.) 
By the 6th month the innermost part or the central cavity of bone shafts of long 
bones is developed. Primary ossification centres are apparent in the middle of 
long bones between 6th and 16th weeks. When one is born, one has what are 
termed secondary ossification centres, located in the epiphyses ( rounded end )  
of long bones. These centres appear just before birth and ossify in the late 
teenage years when skeletal maturity is reached. These centres allow bones to 
continue growing in a child after birth. During growth these areas, known as 
epiphyseal plates, maintain a constant thickness. (Schoen 2001,55.)  
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In the beginning of adulthood  the cells in the plates divide less often and the 
plates become thinner and thinner until they are entirely made up of bone. The 
period when bone mass increases significantly in a human being is in 
adolescence years. (Gordon et al 2004).  
The parathyroid hormones function is to regulate calcium homeostasis by 
increasing the release of calcium from bone and resorption of this from the 
kidneys. It plays a significant role in formation and maintenance of bone. 
(Downey & Siegel, 2006.)  
Another endocrine function is that of the thyroid gland, which synthesises a 
polypeptide hormone known as calcitonin. Calcitionin has an inhibitory action on 
osteoclasts, thus lowering serum calcium levels (Downey & Siegel, 2006). Other 
hormones that influence bone growth and density include glucocorticoids, 
thyroid hormones and oestrogens. The average age at which maximum bone 
density is attained is 30 years and 50% of peak bone mass is accumulated 
through the adolescent years (Golden, 2003). If the body is able to reach peak 
bone mass during this adolescent years , the bone mass later in life can remain 
stable and consequently decrease the risk for osteoporosis. (Gordon et al 
2004,4.)  
After the average age of peak bone mass attainment which is 30 years, there is 
a 1-2 % decline in bone mass each year until menopause. At this time, bone 
mineral density levels decrease rapidly due to low oestrogen levels and women 
lose up to 40% of their total bone mass after menopause. Oestrogen plays a 
significant role in minimising bone loss in women. This hormone works to 
protect the bones in three ways: 
a) It suppresses osteoclastic activity and increases the number of 
vitamin D receptors on osteoblasts. 
b) Promoting renal reabsorption of calcium and helping to promote 
the intestinal absorption of calcium. (Anderson et al  2005, 305.) 
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c) Promotes osteoblastic activity, increasing the growth of new 
bone and causing the thyroid gland to produce calcitonin, providing 
even more protection at a cellular level. 
After menopause the ovaries stop functioning and this results in the absence of 
oestrogen which alters skeletal homeostasis. As a result postmenopausal 
women experience bone loss density. (Maher et al 2002,66.) 
When peak bone mass is attained the bones are at the strongest state. If the 
bones are strong at the formative years, there is a significant decrease for 
developing osteoporosis later in life, the first two years of life and the early 
adolescent years being  the most vital. Bone gain and loss is a cycle in that the 
amount of bone mineral gained during adolescence equals the amount lost 
throughout the rest of adult life. A balanced diet is hence of utmost importance 
during this formative years of life. (Bailey et al 2000,2245.) 
What makes bone hard is its mineral content  and bone’s mechanical strength is 
determined by  structural protein collagen. The bones of the adult skeleton 
comprise two types of tissue, cortical or compact, and cancellous or spongy 
bone. Most bones consist of an outer cortical sheath enclosing a trabecular 
network of cancellous bone that houses the marrow. The cortical sheath is 
bounded outside and inside by the periosteal and endosteal surfaces, 
respectively. The endosteal surface of the cortical sheath is connected to 
cancellous bone and consists of interconnected rods and plates. This structure 
maximizes strength while minimizing weight. The rods and plates of the 
cancellous network are preferentially oriented along the lines of mechanical 
strain of the bone. In adults, 80% of the skeleton is cortical bone. (Fleisch H 
1997,11.) 
However, the relative proportions of cortical and cancellous bone vary in 
different parts of the skeleton. For instance, in the lumbar spine, cancellous 
bone accounts for about 70% of the total bone tissue, whereas in the femoral 
neck and radial diaphysis, it accounts for about 50% and 5%. (Fleisch H 
1997,11.) 
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The main function of bone is to  support the body and protect internal organs 
from injury. The process of bone renewal  happens continuously is all adults 
and small amounts of bone are broken down and replaced by new bone known 
in. Bone marrow is found inside the bone and it  produces large numbers of 
blood cells. Bone is also an essential reservoir of minerals for the body. 
Minerals like calcium phosphate and calcium carbonate, fluorides and chlorides 
are moved from other parts of the body to the bone and back again under the 
influence of hormones, specialised bone cells and during exercise. (Schrader, 
et al 2005, 55.) 
The dense outermost bone is known as cortical bone while the more spongy 
internal form is known as cancellous or trabecular bone. Bone is categorized 
into four levels namely, normal bone mass, low bone mass where the BMD  is 
lower than normal, osteoporosis in which fractures have not yet occurred and 
severe or established osteoporosis when fractures have occurred.  
(Limpaphayom et al 2001,64.) 
To further expound on this categorization of bone, normal bone means  a value 
of BMD greater or less than one standard deviation below the peak bone mass 
of healthy adults. Osteopenia means a  value of BMD between 1.0 SD and 2.5 
SD below the average value of the peak bone of healthy adults. Osteoporosis 
means a value of BMD more than 2.5 SD below the average value of the peak 
bone mass of health adults. (Limpaphayom et al 2001,65.) 
2.2 Peak bone mass 
Peak bone mass is the amount of bone tissue present at the end of skeletal 
maturation. It is a major determinant of the risk of fracture due to osteoporosis 
since the mass of bone tissue at any time during adult life is the difference 
between the amount accumulated at maturity and that lost with ageing.  
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In adolescent girls, the gain in BMD declines rapidly after menarche and is 
insignificant 2 years later. (Bonjour JP et al1994,55.) 
In adolescent boys, the gain in BMD or in bone mineral content  is particularly 
rapid between the ages of 13 and 17 years but declines markedly there after in 
all sites except the lumbar spine and mid femur, where growth continues until 
the age of 20 years. However, no significant increase in BMD is observed at the 
femoral neck. During late puberty, when height is increasing by less than 1 
cm/year, the gain in bone mass is still significant in males but not in females. 
This suggests an important sex difference in the magnitude and/or duration of 
the so-called consolidation phase that contributes to the ultimate peak bone 
mass. (Fournier P et al 1997,525.) 
 
2.3 Diagnosis and screening Osteoporosis 
The World Health Organization definitions of osteoporosis and osteopenia in 
postmenopausal  is based on bone mineral density (BMD). Osteoporosis is 
diagnosed by carrying out a  central dual-energy x-ray absorptiometry test  
(DXA) of the hip. This  is a non invasive procedure which produces  accurate 
results. (Kanis & Glüer 2002,192.) 
Density measurement in gm/cm2, and T and Z scores are the universally 
recognized measurements for reporting the results. T scores represent the 
number of SDs from the mean bone density values in same sex matched young 
adults. For dual energy X-ray absorptiometry a comparison is made between  
soft tissue and bone penetration of two different X-ray sources. Soft tissue is 
then subtracted  leaving an estimate of skeletal BMD. This takes less than 10 
minutes, and the person is exposed to  radiation  about three to four  mrem/site. 
By comparison, background radiation is about 300 mrem/year. DXA can assess 
various sites in the body but it recommended that  BMD of the non dominant hip 
be assessed. It is an excellent predictor for hip fracture and an an excellent 
preditor of vertebral or wrist fracture. (Mc Court et al 2010,8.) 
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The T score is used to make a diagnosis of normal bone density. Z scores 
represent the number of SDs from the normal mean value for age and sex 
matched control subjects. If the A Z score are less than 1, the presence of 
secondary osteoporosis is likely. Z scores assess bone loss in premenopausal 
females and in men who are below 50 years of age. A Z score of –2.0 or lower 
is defined as below the expected range for age, a Z score above –2.0 is within 
the expected range for age. (Leib et al 2004,1.) 
 
2.4 Pathophysiology of osteoporosis 
Bone formation happens continuously and several factors determine how this 
goes on namely: Estrogen and progesterone stimulation, dietary and the 
amount of stress put on the bone. For  bone to remain healthy, the process of 
bone break down and bone formation have to remain balanced. (Kowalak et al 
2001,50.) 
Osteoblasts are cells that continually form bony matrixes to replace areas of 
bone that have been digested by phagocytic cells called osteoclasts. The 
continual process of bone remodeling through osteoblast and osteoclast activity 
amounts to a preventive maintenance program allowing for a healthy skeleton 
(National Osteoporosis Foundation, 2006).  
Any alteration during remodeling results is bone thinning or osteoporosis.For 
bone remodeling to remain stable, proper level of estrogens and progesterones 
are required. ((Hawkins et al 2005,6.) 
There are two processes of bone loss. Rapid bone loss that takes place during 
menopause and is osteoclast mediated. Osteoclast is a large multinucleate cell 
found in growing bone that resorbs bony tissue, as in the formation of canals 
and cavities. (Finkelstein 2004.) 
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The other one is gradual bone loss which takes place after menopause and is 
osteoblast mediated. Osteoblast are mononucleate cells that are responsible for 
bone formation.  (Finkelstein 2004.) 
In a healthy adult it takes 4 months to complete one cycle of bone remodeling. 
In a person with osteoporosis it takes 2 years. For osteoporosis not to occur the 
bone remodeling process needs to occur without interruption. It takes the 
following steps namely: Cluster of bone precursor cell respond to stimulus  
which could be in the form of  drugs , hormones or physical stressor to activate 
the remodeling process and form osteoclasts which in turn form a cutting  cone 
and begin to resorb bone leaving a resorption cavity. In cortical bone  
osteoblasts line the cavity and begin laying down layers of new bone until a 
harversian canal results. Osteoporosis occurs if this process  of remodeling is 
interrupted. (Monahan 2007,1579.) 
Other ways that also bring about osteoporosis are a decrease in the number of  
bone precursor cell, a decrease in the rate of bone formation, an increase in the 
rate of bone resorption or an increase in the number of stimuli that activate the 
process and if the whole process is not completed in entirerity. The bone’s 
vascular system should also not be interfered with. (Monahan 2007,1579.) 
3 THE RISK FACTORS FOR OSTEOPOROSIS 
 
There are many factors that increase the risk of a person developing 
osteoporosis. Individuals with more risk factors are at greater risk of 
osteoporosis  and this can further be divided into non modifiable meaning that 
an individual has no control over them and modifiable risk factors for 
osteoporosis meaning the individual can make life style changes to change and 
control the development of osteoporosis. 
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3.1 Non modifiable risk factors for osteoporosis 
Genetic factors  account for up to 80% of the difference in peak bone mass and 
bone turnover  as well as contributing to the occurrence  of osteoporotic 
fractures. Parental history of osteoporotic fracture, especially a family history of 
hip fracture over the age of 50 years, increases an individual's risk of 
experiencing a fracture. (Kanis et al 2004.) 
During  menopause the ovaries produce lower levels of estrogen. This results in 
an acceleration of bone loss following menopause compared to that in the third 
decade. The average age at which women in the UK reach the menopause is 
51 years. Premature menopause therefore results in the early acceleration of 
demineralisation and is a risk factor for osteoporosis in the future. Similarly, 
hysterectomy with bilateral oophorectomy causes instant menopause and 
should also be considered an increased risk for osteoporosis in pre-
menenopausal women. (NOS 2006) 
Age and gender is another non modifiable risk factor. Bone mineral density 
decreases with age and therefore the risk of osteoporosis increases. There is a 
significant increase in the prevalence of osteoporosis at the age of 60 and for 
subsequent decades. Changes in age is more important than changes in bone 
mineral density in predicting fracture risk. Women are typically at greater risk of 
osteoporosis than men and this is attributed to the fact that they have smaller  
bones and a lower total bone mass. (SIGN 2003). 
Ethnicity also  plays a role in terms of bone mineral density. Afro-Caribean 
women have a higher bone mineral density than Caucasian women and this 
factor is at any ginen age be it in adolescent or adulthood. They also have a 
higher peak bone mineral density and they lose the bone at a slower rate. 
(Barrett-Connor et al 2005.) 
History of previous fracture.  According to Nelson et al 2001, women who have 
had a fragility fracture are at increased risk of future fractures irrespective of 
bone mineral density. Adults who sustain a fracture are more than 50% more 
likely to have another fracture of a different type. (NOS 2006). 
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Similarly, women with one existing vertebral fracture have a five fold greater risk 
of vertebral fracture  Furthermore most  post menopausal women who have had 
a vertebral fracture will experience a second within a year. (NOS 2006).  
Those who have already fractured  are at greatest risk of further fracture, 
including those with a thoracic kyphosis, which may be indicative of previous 
osteoporotic fracture. (Cummings et al 1998.) 
3.2  Modifiable risk factors for osteoporosis 
Smoking leads to higher incidence of fractures, decreased bone healing , a 
decrease in new bone formation, a decrease in mineralization of bones in the 
hip, hand forearm and heel. Previous smoking also results in an increased 
fracture risk, although the risk is lower than that of current smokers. Weight is 
also another modifiable risk factor. A body mass index (BMI) less than 19 is an 
indicator of a low bone mineral density (SIGN 2003), with those in the lowest 
strength of BMI having a greater risk of bone loss in comparison to those in the 
highest tensile. Post menopausal women with a BMI that is below average have 
an increased risk of osteoporosis (Ravn et al 1999). 
Vitamin D plays a fundamental role in calcium absorption and over all bone 
health. It facilitates the intestinal absorption of filtered calcium and reabsorption 
of fiitered calcium from the glomerular tubules within the kidneys back into the 
plasma. Calcium is also essential for healthy new bones and may be acquired 
through dietary intake or the use of supplements. Vitamin D levels  positively 
relate to bone mineral density. (SIGN 2003.) 
The impact of exercise to bone mass density is immense. During periods of 
prolonged bed rest, bone loss typically occurs at 1-2% per month. Physical 
activity can delay the progression of osteoporosis from the late 20s by slowing 
the rate at which bone mineral density is reduced. People who do not do any 
physical activity , have a greater at risk of developing osteoporosis.  
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When a tennis players hands are compared, the hand that the player uses to 
play has a higher bone mineral density and this indicates that physical activity 
plays a mojor role in the strength of bones.  When balance and strength 
exercises  are performed, the risk of falling is significantly reduced by increasing 
strength and flexibility. (Chang et al 2004,532.) 
3.3 Complication of osteoporosis 
Once osteoporosis has occurred, fractures occur making it the most  notable 
consequence of osteoporosis. Effects of osteoporosis happen to any bone in 
the body,  but the most common sites of fractures are the hip, spine, and wrist 
(NOF, 2006). Age  determines where the fracture will occur. For individuals in 
who are aged 50 years, fractures tend to happen at the wrist, at 60 years 
fractures occur  at  the vertebrae of the spine, and at  70 years, the  occurrence 
is at the hip. In all this fracture sites the hip fracture is more pronounced with 
age. (Melton 1996.121.) 
Consequences of decreased bone mass are skeletal fractures and other 
complications related to bone loss. This complications are abdominal 
protrusion, height loss, and kyphosis secondary to multiple vertebral fractures, 
acute and chronic pain resulting from fractures, decreased respiratory capacity, 
and increased morbidity and mortality rates. Quality of life diminishes as a result 
of this complications. The pain associated with this fractures is also immense  
and the affected are bound to suffer loss of self esteem. (Maxwell & Viale 
2005,589.) 
Death from hip fractures are also inevitable and this deaths can occur within a 
year of sustaining a fracture. After sustaining hip fractures carrying out daily 
activities is no longer possible and the individuals  have to be helped to do what 
they were able to do. This adds to the burden of increased health care costs 
because long term home or hospital care is needed. Back pain, loss of height, 
depression, and low self-esteem are also complication of this disease. (Brown 
et al 2006,95.) 
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The burden of this disease continues after  the patient has been discharged 
from the hospital so it becomes a life time burden for the patient and her family. 
(Brown et al 2006,95.) 
It is expensive to diagnose and manage osteoporosis and more so if surgical 
intervention are sought or when acute episodes occur.The patients and family 
members have to make lifestyle adjustments due to the financial and 
psychological impact. (WHO, 2003.) 
The cost of osteoporosis is both direct and indirect. Direct costs include hospital 
costs inccured during treatment. Indirect costs are patient’s loss of income, loss 
of a job and adjustments in the household. Intangible costs that cannot be  
quantified  in monetary units are when the patient become immobile, costs in 
relation to human suffering, death , reduced productivity as well as health care 
costs (Ribeiro et al,2000).  
Occurrence of death within the first year of sustaining hip fracture is up to 
25%.If survival occurs beyond a year, long-term institutional care is required. 
Caring for an elderly person who is also affeceted with osteoporosis affects the 
direct costs of managing osteoporosis related fractures. The costs of hip 
fractures are twice as high in the elderly than in younger patients.  (Berarducciet 
al  2002,19.) 
4 TREATMENT AND PREVENTION  
Early and effective interventions are necessary to reduce the risk of future 
fracture. It is vital to consider what kind of information is relevant for the various 
age groups in order for them to prevent or manage osteoporosis at different 
times in their life. For example, school age, post menopausal  or older age. 
4.1 Nonpharmacological interventions 
Eating a balanced diet that includes adequate calcium and vitamin D, using 
supplements when necessary, engage in regular physical activity, avoid heavy 
alcohol consumption, and refraining from smoking is a good way to prevent 
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osteoporosis. Glucocorticoid-induced osteoporosis prevention. Minimize 
exposure to glucocorticoid by using the lowest effective daily dose for the 
shortest period. When possible, use inhaled or topical rather than oral 
preparations, although high dose inhaled steroids have also been shown to 
cause bone loss. (Mc Court et al 2010,8.) 
Every other day dosing has not been shown superior to daily dosing with 
respect to bone loss. Consider preventive therapy for any patient taking 
glucocorticoids, regardless of dose or duration: For patients taking lower doses 
for shorter durations (e.g., prednisone less than 5 mg daily for fewer than 3 
months), who have no history of bone loss,calcium and vitamin D 
supplementation is recommended.For those with pre-existing bone loss, 
bisphosphonate therapyis recommended. (Mc Court et al 2010,8.) 
For higher doses of glucocorticoids  that is prednisone more than 7.5 mg daily 
for longer than 6 months, bisphosphonates should be prescribed as they have 
been shown to prevent glucocorticoid related bone loss at both the lumbar spine 
and femoral neck, and to reduce the risk of vertebral fractures. A large number 
of substances have been used to treat osteoporosis, and the patterns of use 
vary greatly from country to country. For example, fluoride is widely used in 
Germany, but is not licensed to use in United Kingdom or USA. Calcitonine is 
mainly used in Japan and USA. The choice of agent will depend not only on 
effectiveness but also on other considerations such as side effects, cost and 
availability. (WHO,2003.) 
Intake of calcium and vitamin D is necessary to decrease bone deterioration. 
Ninety nine percent of the body’s calcium stores are contained in the skeleton. 
When an exogenous calcium supply is inadequate, the body draws from the 
stores to maintain serum calcium levels. (National Osteoporosis Foundation.) 
Calcium supplements decrease the amount of calcium drawn from the bone to 
replace the exogenous supply. A daily dose of 1,200 mg per day is 
recommended. (National Osteoporosis Foundation.) 
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Vitamin D (400–800 IU per day recommended) facilitates the process by 
helping the body to absorb the calcium from the intestine and use it in the 
bloodstream. It also assists the kidneys to resorb calcium that otherwise would 
be excreted. (National Osteoporosis Foundation.) 
Weight  bearing exercise effectively  increases bone density at the lumbar spine 
and hip in postmenopausal women and helps bones  become stronger and 
denser. Weight-bearing exercises, during which muscles and bones work 
against gravity, and resistance exercises to improve muscle mass and 
strengthen bone are important for building and maintaining bone mass and 
density (National Osteoporosis Foundation.)  Weight bearing  excercises  in are  
walking, aerobics, and resistance exercises. Exercise is also important in 
increasing muscle mass and strength and  improving  balance and coordination. 
(Taaffe et al 2009,1208.) 
Physical therapy can also be incorporated  to improve strength and balance. 
Medications that may interfere with an individuals mental status and movement 
stability should be avoided.Elimination of environmental hazards in the home is 
also of utmost importance. (Hughes et al 2004,291.) 
4.2 Phamacological interventions. 
Pharmacological therapy aims at  is to reducing the risk of future fracture, and 
also increasing  bone density. Pharmacological agents for treatment of 
osteoporosis fall into 1 of 2 categories: antiresorptive agents or anabolic agents. 
All the currently available drugs except teriparatide are antiresorptive agents. 
These agents reduce bone resorption more than promote bone formation and 
thereby suppress bone turnover and loss, whereas anabolic agents stimulate 
bone formation more than reduce bone resorption. (Marcus et al 2002,16.) 
Bisphosphonates block bone resorption by inhibiting osteoclast activity. The  
bisphosphonates that are currently FDA approved for osteoporosis treatment 
and prevention are alendronate, risedronate, and ibandronate  
bisphosphonates.  ( Griffith et al 2002,570.) 
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These agents significantly reduce vertebral and hip fractures by half in 
postmenopausal women. For all oral bisphosphonates, patients should take 
each tablet with 6 to 8 ounces of plain water first thing in the morning and at 
least 30 minutes before ingesting the first meal, beverage, or medication of the 
day. Patients should not remain upright for at least 30 minutes (60 minutes with 
ibandronate) to reduce the potential for esophageal injury. ( Griffith et al 
2002,570.) 
Raloxifene is a selective estrogen receptor modulator that is  used for both the 
prevention and the treatment of postmenopausal osteoporosis. It selectively 
inhibits or stimulates estrogen like action in various tissues. For example 
exerting an estrogen agonist effect in some areas e.g bone and lipid 
metabolism, while acting as an estrogen antagonist in others e.g breast and 
uterus.The dosage used is  of 60 mg/d and it is known to decrease vertebral 
fractures by half. (Ettinger et al 1999,637.) 
Another pharmacological intervention is the use of salmon calcitonin nasal 
spray. It is FDA approved for treatment of osteoporosis. The approved dosage 
is  200 IU  every day in alternating nostrils . It inhibits bone resorption, which is 
the process by which osteoclasts break down bone and release the minerals, 
resulting in a transfer of calcium from bone fluid to the blood and this results in 
the prevention of  bone loss and vertebral fractures and decreases  pain  that is 
associated  with acute or subacute vertebral fractures. Compared with other 
treatments, it has low potency  and it is therefore prescribed to osteoporotic 
women who are unwilling or unable to take other osteoporosis agents. It’s side 
effect is mild to moderate rhinitiswhich is nasal congestion,  discharge, or 
sneezing. (Chesnut 2000,267.) 
Teriparatide is another drug used for  treatment of osteoporosis. It increases 
bone density and reduces both vertebral and non vertebral fractures by over 
half. It has a great advantage in that 18 months after discontinuing treatment 
the reduction in vertebral fracture risk continues.  
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It is given in a daily dosage of  20-μg subcutaneously for a maximum duration of 
2 years. It is recommended for individuals at high risk for fractures (T scores 
less than –3.5), even in the absence of pre existing fracture. It is an alternative 
for patients who are unable to tolerate oral bisphosphonates. (Lindsay R et al 
2004,164.) 
Another prevention option is estrogen or hormone therapy. The dosage should 
be as low as possible and the duration of time used should also be short. 
According to some experts estrogen therapy is still the first line therapy for 
osteoporosis prevention in younger women with surgical menopause who have 
no contraindications to its use.  In the immediate postmenopausal years  the 
short term use is five to seven years for prevention of osteoporosis and often for 
the treatment of hot flashes in women who have no contraindications to its use. 
(Cauley et al 2003,1731.) 
Long term estrogen based therapy  use is discouraged because of  an increase 
risk of adverse health outcomes, such as stroke and venous thromboembolic 
events. Breast cancer risk is likely but to a smaller degree in women receiving 
combined estrogen progestin therapy. Combination therapy is another 
treatment option that is reccommeded for patients who have severe 
osteoporosis. It is started  by a bone specialist and he should monitor it closely. 
Risedronate and alendronate, as well as calcitonin, increase BMD when 
combined with hormone replacement therapy. (Ettinger et al 2004,746.) 
5 PURPOSE AND AIM 
 
The purpose of this thesis is to provide patient education on prevention of 
osteoporosis in menopause. The aim of this thesis is to produce information in 
terveys netti (health web) and create webpages that can be used by the general 
public to access information on this silent killing disease. 
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6 IMPLICATION OF THE PROJECT TASK 
 
The expected outcome of this project is to produce webpages for Terveysnetti. 
Terveysnetti is an online public health education webpage created by the Salo 
District Health Centre, Salo District Hospital and the Salo Local government 
with the cooperation of Turku University students.  
The main purpose of Terveysnetti is to provide health education with the sole 
aim of improving the health of general population hence empowering them with 
essential knowledge. The contents of this thesis provides exactly that and with 
easy access.  
The contents of this bachelor thesis will provide information to premenopausal 
women. Men are also encouraged to to seek information from this bachelor 
thesis as well because in most cases it’s a spouse who is undergoing this 
changes. The general population also needs this information because this are 
inevitable changes that will happen to every women.  
7 HEALTH EDUCATION 
WHO defined health education as consisting of consciously constructed 
opportunities for learning involving some form of communication designed to 
improve health literacy, including improving knowledge, and developing life 
skills which are conducive to individual and community health. (WHO, 2003.) 
This chapter is meant to produce information about the health education. 
Education is essential for patient with osteoporosis due to its silent nature and 
sudden occurrence of fractures. Health education can reduce anxiety and fear 
of the future. Once people are equipped with  knowledge about the disese they 
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are able to make good choices about health related behaviours. (Laslett et al 
2004,121)  
Many women are concerned with prevention measures but the levels of their 
knowledge and self efficacy are low. (Phillipov 1998,582-556). Impacting 
knowledge in the risk factors and how to avoid them while there are factors that 
are not within the control of the patient. Among non modifiable factors are 
previous minimal trauma fracture, age , family history, female gender and early 
menopause. (Evidence to Support the National Action Plan for Osteoarthritis, 
Rheumatoid Arthritis and Osteoporosis,2004.) 
The components of education strategies could be in form of: 
a) Increasing knowledge about osteoporosis.  
b) Increasing self efficacy. 
Osteoporosis education programs  should incorporate a wide age group that is 
from adolescents to premenopausal women and postmenopausal women  
because all this group of people are prone to develop osteoporosis. Those at 
lower  risk of osteoporosis may benefit once education is availed because they 
can include health related behaviours .Older people at higher risk  can gain 
confidence in ensuring treatment or prevention options that may be suitable for 
them. (Lorig et al 1999,5-14) 
When giving health education for osteoporosis is BMD testing should be 
encouraged for all women aged 65 and older due to their  high risk of 
osteoporosis and fractures. Encourage people to maintain peak bone mass  
because entering  adulthood with low peak bone mass posesa  great risk of 
developing osteoporosis and asscociated fractures . (Hansen et al 1991.) 
Encourage people to do exercise regularly  and more so   resistance and impact 
exercises and to start it early in life because this contributes to higher peak 
bone mass. In postmenopausal women, BMD at the spine can be positively 
affected by aerobics, resistance, and weight-bearing exercise. Encourage 
setting of  personal goals that are both short term and long term.  
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These goals  specific, measurable, attainable, relevant and time based. (Kelly et 
al 2002,599.) 
 A specific short term goal may be to start strength training. The long-term goal 
may be easing the symptoms of osteoporosis or increasing bone density to help 
combat osteoporosis, improving balance, or controlling your weight. This goal is 
easily measurable and attainable as long as your doctor approves, and this goal 
is certainly relevant to living a long healthy life. The goals should be time-based. 
(Centers for Disease Control and Prevention, 2011.)  
Letting the women know about osteoporosis pathology and bone anatomy. 
Encourage family planning and increase awareness as well because women 
loose a lot of calcium during lactation and do not replace it in adequate 
amounts. An effective family planning programme could therefore go a long way 
in the prevention of osteoporosis. Women with more children to take care of 
could also be nutritionally deprived in underprivileged circumstances, and have 
little time and resources to consume a calcium-rich diet or engage in bone 
strengthening exercises. (Mc Cable et al 2004,1066.) 
Encourage use of calcium rich food at least four times a week to ensure that the 
bones are well mineraliszed and attainment of peak bone mass. For  
postmenopausal women, calcium supplements slow boneloss and improve 
BMD. Dairy products  are a good source of calcium and increases BMD. (Mc 
Cable et al 2004,1066.) 
Discourage use of all forms of smoking tobacco as well as use of smokeless 
tobacco.There is direct relationship between tobacco use and decreased bone 
density. Smoking has been shown to decrease calcium absorption. Women who 
smoke also tend to have an earlier menopause than nonsmokers because they 
tend to produce less estrogen. (Eustice 2006,1.) 
High risk individuals should be screened and identified and this depends on the 
clinical situation for example hoe severe the fractures are. Central DXA scans 
may be repeated in 1 to 3 years. (Khan et al 2002,1142.) 
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This is monitors the response to a pharmacologic therapy or to document the 
stability of bone density in untreated patients at risk for bone loss and to 
improve adherence to therapy. (Khan et al 2002,1142.) 
Corticosteroid induced osteoporosis should be avoided because  they affect 
calcium and bone metabolism in many ways. They decrease the amount of 
calcium absorbed by the intestine and they also increase calcium excretion 
through the kidneys. These in turn  produce a decline in the circulating ionized 
calcium concentration. (Leufkens, et al 2000,993.) 
This makes the  parathyroid glands to be over actice and this  increases the 
secretion of parathyroid hormone (PTH), and the patient suffers from secondary 
hyperparathyroidism.  Once the PTH levels are high  bone breakdown is 
increases , as the body attempts to rectify low circulating calcium levels by 
releasing calcium from the bones into the blood. Corticosteroids also decrease 
the levels of the sex hormones, estrogen in women and testosterone in men 
and bone loss increases . Muscle weakness is also another side effect of 
corticosteroids and due to the  inactivity that comes about  and  bone loss 
occurs. Direct impact that is associated with corticosteroids is suppression of  
bone formation . (Leufkens, et al 2000,993.) 
Develop awareness of the risks of excessive alcohol intake. Chronic alcohol use 
has been linked to an increase in fractures of the hip, spine, and wrist. Too 
much alcohol interferes with the balance of calcium in the body. It also affects 
the production of hormones, which have a protective effect on bone and of 
vitamins, which are needed to absorb calcium. Excessive alcohol use can also 
lead to slips and falls. (Eustice 2006,1.) 
Treatment of osteoporosis has had limited success. Prevention is preferable to 
treatment, since no therapy fully restores lost bone mass. Prevention is a more 
useful approach, and ideally, women at high risk should be identified before 
menopause when preventive measures can be instituted. Whether single 
measurements of bone density in women who are at risk can identify those who 
should be treated is a point of controversy. (Cummings 1986,820. 
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8 ESTABLISHING WEBPAGES 
In today’s world, the widely and most common medium of accessing information 
is through webpages. This is due to easy accessibility at any time and any 
location. Designing webpages is also important in order to reach the target 
population. Establishing webpages begins by preparing the contents. All the 
information that  is going to be provided come from researched articles and 
books. Webpages encourage the passing out  of quality health information for 
patients and professionals and the general public and by so doing the above 
mentioned/ targeted population are able to access the most recent and relevant 
health information. ( HONcode) 
The target group are mostly adolescent women in preparation for their 
menopause stage of life but also useful for the men. In creating this webpage, 
content of the webpage is well organized and the flow of information is perfectly 
clear. The language construction is simple so that uneducated target groups 
can benefit. Useful links were provided from several parts of the world for 
further information and guidelines. While designing the webpage comfortability 
of both educated and non educated group was made priority. 
The information that will be provided in the webpages will be a summary of the 
whole bachelor thesis and what is contained in the bachelor thesis is 
information from researched articles, read through and finally analysed. The 
information provided is intended for patient education and hence the webpages 
will be designed to do excactly that and it will be simple and easy to understand. 
9 RELIABILITY   
In the process of getting relevant information about the topic of this bachelor 
thesis, literature review was used. The reasons for using this method  is that 
with some modification of the original literature, it becomes legitimate and 
publishable. It is  an information analysis and synthesis, focusing on findings 
and summarizing the substance of a literature and drawing conclusions from it. 
(Boote & Beille 2005,5.)                                                   
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All the materials used in this thesis were collected from health care database 
and books. The materials were considered and accepted as valid and reliable. 
Biased and personal opinions were not used with literature review. Reasonable 
number of searches were used to provide enough information and to support 
the teaching. However the topic was approved by my supervisors before 
proceeding and continuous checks are done on it until this stage to make sure it 
is close to perfection. 
The articles selected were reliable because they had all the information on 
prevention of osteoporosis in menopause. Reliable articles were identified from 
different databases namely, Cinahl, Science direct and  books from the school 
library. The same procedure was followed in each database. The articles were 
read thoroughly in order to identify their relevance in terms of content and the 
results obtained.In the process of finding relevant material for this bachelor 
thesis, several searches have been done and with changing and using different 
search words all related to the thesis topic. The searches were conducted using 
several words as my appendix shows. After searching two words, a combination   
with or and later with and yielded several results.  
The end result was 30 articles of which 16 were full text. Most of them did not 
have relevant material hence another search was conducted using two words. 
Osteoporosis and menopause. The search was limited year 1998 - 2010 with 
the exception of ones that was done in the year year below 1998 owing to their 
very relevant material.  
The articles were read through and several articles were picked to be used in 
the literature review owing to their relevance in the topic on osteoporosis. 
Science direct and Cinahl were used. To get final and relevant articles, the use 
of the preventing osteoporosis in menopause as a search term was preferred. 
In the process of carrying out literature review  plagiarism was avoided and this 
was achieved by understanding the text and wording it differently without 
changing the meaning and that is vital in ethical consideration.  
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All the  articles were searched from recognized search tool as indicated above 
and all were professional, peer-reviewed scientific journals. ethical 
consideration 
10 ETHICAL CONSIDERATION 
 
In the process of of carrying out literature review plagiarism was avoided and 
this was achieved by understanding the text and wording it differently without 
changing the meaning. All the articles were searched from recognized search 
tools as indicated above and all were professional peer reviewed scientific 
journals. Formal language was used and not forgetting that this is a continuing 
situation or disease in that the information on prevention was true in the past, is 
true presently and will be true in the future. Only medical interventions might 
change. 
11 CONCLUSION 
 
Regular physical activity, healthy eating and not smoking can prevent and 
alleviate problems associated with age-related loss of muscle strength and 
bone density. Policies and programmes need to dispel misconceptions about 
the menopausal period and encourage ageing women to adopt healthy lifestyle 
behaviours that will help them cope with the physical symptoms of menopause 
and bone loss. (WHO,2007) 
However, osteoporosis should no longer be considered an old womans disease 
but rather young women should also be included. It should be viewed as a life 
long concern and special attention should be given to adolescent years. Up to 
95% of total bone development is completed before the age of 18. Women’s 
bone strength depends upon this period of rapid growth and the skeletal mass 
achieved during the first two decades of life. (Cavadin et  al 2000,18.) 
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Any factors adversly impacting bone acquisition during adolescence have the 
potential to yield long term detrimental effects. Care givers should address 
factors affecting bone health when giving patient education to adolescents in 
order to promote bone growth and adult peak bone mass. When addressing 
osteoporosis prevention in adolescent’s the educator must establish the 
adolescent’s knowledge of bone health and establish their dietary patterns. 
(Cavadin et  al 2000,18.) 
Osteoporosis is a health problem that has an impact on peoples health globally.  
The most important years for bone development are during adolescence. 
Challenges and threats during this formative years  result in negative  health 
outcomes later on in life. The decisions and actions decided upon by 
adolescents will influence their lives in later years. This age group  should be a  
target  in the management of health related issues.  Health promotion strategies 
are needed to address this age group  order to achieve  positive outcomes later 
in life. (Cadogan et al 1997,1255.) 
Many women are not diagnosed with osteoporosis until they have sustained 
one or more fractures, despite advances in diagnosis and therapeutic 
interventions. Priority should be directed towards finding and managing patients 
who have the highest risk of falling and experiencing fracture (S1GN 2003). 
Falls are a significant risk factor for fractures and therefore the assessment and 
management of the risk of falling are as important as treating osteoporosis. The 
risk factors associated with falls increase with age, resulting in an increased 
frequency of falls. As many older people do not seek advice following a fall, it is 
important to actively seek the history of falls during consultations. Falls 
assessments should be comprehensive. Advocate the use of multifaceted 
interventions to reduce the incidence of falls in older people, such as gait 
training, use of assistive devices and exercise. (The American gieriatrics 
Society 2001.) 
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Finally the webpages contain valuable information that the general public will 
have access to. The information that will be provided in the webpages will be a 
summary of the whole bachelor thesis and what is contained in the bachelor 
thesis is information from researched articles, read through and finally analysed. 
The information provided is intended for patient education and hence the 
webpages will be designed to do excactly that and it will be simple and easy to 
understand. 
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